Abstract
It is still not clear whether intact lipid vesicles can cross the human skin. Some reports in the literature indicate that transfersomes® can cross the skin. Other reports suggest that intact liposomes cannot cross the skin. Of course, the composition of the various formulations has to be taken into consideration before making such assertions. The present review examines the use of vesicles- elastic liposomes and ethosomes- for transdermal drug delivery. Liposomes are micro- or nano-structures formed from a bilayer of lipid surrounding an aqueous core. Elastic liposomes differ from conventional liposomes because they contain edge activators (surfactants) which impart elasticity and deformability. Ethosomes are efficient in facilitating percutaneous drug penetration. They are structurally similar to conventional liposomes in the sense that they are prepared from phospholipids but different because they contain a high concentration of ethanol. Both elastic liposomes and ethosomes are increasingly being used for delivering low and high molecular weight drugs. In this review, several reports are presented showing the usefulness of these vesicles and mechanistic insight sought as to why they may be effective in certain cases.
Keywords: Elastic liposomes, ethosomes, transdermal, dermal, vesicles.
Current Pharmaceutical Design
Title:Current Status of Ethosomes and Elastic Liposomes in Dermal and Transdermal Drug Delivery
Volume: 22 Issue: 33
Author(s): Kevin Ita
Affiliation:
Keywords: Elastic liposomes, ethosomes, transdermal, dermal, vesicles.
Abstract: It is still not clear whether intact lipid vesicles can cross the human skin. Some reports in the literature indicate that transfersomes® can cross the skin. Other reports suggest that intact liposomes cannot cross the skin. Of course, the composition of the various formulations has to be taken into consideration before making such assertions. The present review examines the use of vesicles- elastic liposomes and ethosomes- for transdermal drug delivery. Liposomes are micro- or nano-structures formed from a bilayer of lipid surrounding an aqueous core. Elastic liposomes differ from conventional liposomes because they contain edge activators (surfactants) which impart elasticity and deformability. Ethosomes are efficient in facilitating percutaneous drug penetration. They are structurally similar to conventional liposomes in the sense that they are prepared from phospholipids but different because they contain a high concentration of ethanol. Both elastic liposomes and ethosomes are increasingly being used for delivering low and high molecular weight drugs. In this review, several reports are presented showing the usefulness of these vesicles and mechanistic insight sought as to why they may be effective in certain cases.
Export Options
About this article
Cite this article as:
Ita Kevin, Current Status of Ethosomes and Elastic Liposomes in Dermal and Transdermal Drug Delivery, Current Pharmaceutical Design 2016; 22 (33) . https://dx.doi.org/10.2174/1381612822666160511150228
DOI https://dx.doi.org/10.2174/1381612822666160511150228 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of Isoprenoid Compounds on Angiogenic Regulation: Opportunities and Challenges
Current Medicinal Chemistry Pharmacological, Immunological, and Gene Targeting of the Renin-Angiotensin System for Treatment of Cardiovascular Disease
Current Pharmaceutical Design Mediterranean Diet, Brain and Muscle: Olive Polyphenols and Resveratrol Protection in Neurodegenerative and Neuromuscular Disorders
Current Medicinal Chemistry Targeting α7 Nicotinic Acetylcholine Receptor to Combat Inflammation in Cardio-Cerebral-Vascular Diseases
Current Drug Targets Pro-Inflammatory Gene Variants in Myocardial Infarction and Longevity: Implications for Pharmacogenomics
Current Pharmaceutical Design Oxidative Stress: Meeting Multiple Targets in Pathogenesis of Vascular Endothelial Dysfunction
Current Drug Targets Editorial [Hot topic: Transportalopathy and Vascular Cell Dysfunction (Guest Editor: Luis Sobrevia)]
Current Vascular Pharmacology Overlooked Issues of Snakebite Management: Time for Strategic Approach
Current Topics in Medicinal Chemistry Nature and Nurture in the Early-Life Origins of Metabolic Syndrome
Current Pharmaceutical Biotechnology HSP60 as a Drug Target
Current Pharmaceutical Design Renal & Ocular Targets for Therapy in Wegeners Granulomatosis
Inflammation & Allergy - Drug Targets (Discontinued) The Therapeutic Applications of Exosomes in Different Types of Diseases: A Review
Current Molecular Medicine Acute Severe Colitis: Infliximab and/or Cyclosporine?
Current Drug Targets An Update on the Management of Severe Cutaneous Drug Hypersensitivity Reactions
Current Pharmaceutical Design Targeting Chemoattractant Receptors in Allergic Inflammation
Current Drug Targets - Inflammation & Allergy Therapeutic Monitoring of Immunotherapies in Autoimmune Diseases
Current Pharmaceutical Design Resistin and Cardiovascular Disease: A Review of the Current Literature Regarding Clinical and Pathological Relationships
Current Cardiology Reviews Natural Products with Antiangiogenic and Antivasculogenic Mimicry Activity
Mini-Reviews in Medicinal Chemistry microRNAs: Promising Biomarkers and Therapeutic Targets of Acute Myocardial Ischemia
Current Vascular Pharmacology Current Update on Eosinophilic Lung Diseases and Anti-IL-5 Treatment
Recent Patents on Anti-Infective Drug Discovery